GT Biopharma
(NASDAQ) GTBP
GT Biopharma Financials at a Glance
Market Cap
$11.79M
Revenue (TTM)
$0.00
Net Income (TTM)
$28.35M
EPS (TTM)
$-14.62
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$0.36
Volume
288,939.5
Open
$0.37
Price
$0.36
Volume
288,939.5
Open
$0.37
Previous Close
$0.36
Daily Range
$0.36 - $0.38
52-Week Range
$0.35 - $3.85
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$0.36
Volume
288,939.5
Open
$0.37
Previous Close
$0.36
Daily Range
$0.36 - $0.38
52-Week Range
$0.35 - $3.85
GTBP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GT Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Michael Breen
Website
www.gtbiopharma.comHeadquarters
San Francisco, CA 94005, US
GTBP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-2219%
Return on Capital
-2%
Return on Assets
-3%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
-0.81%
Stock Overview
Market Cap
$11.79M
Shares Outstanding
31.55M
Volume
288.94K
Short Interest
0.00%
Avg. Volume
886.55K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$12.42M
EBITDA
$34.32M
Operating Cash Flow
$12.91M
Capital Expenditure
$0.00
Free Cash Flow
$12.91M
Cash & ST Invst.
$6.81M
Total Debt
$0.00
GT Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$11.79M
N/A
Market Cap/Employee
$11.79M
N/A
Employees
1
N/A
Net Income
$23.03M
-510.1%
EBITDA
$29.00M
-668.2%
Quarterly Fundamentals
Net Cash
$6.81M
+72.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-3.50%
N/A
Return on Invested Capital
-2.15%
N/A
Free Cash Flow
$4.02M
-62.9%
Operating Cash Flow
$4.02M
-62.9%